- Home
- VALN vs AUXX Comparison
VALN vs AUXX Comparison
Compare VALN & AUXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VALN | AUXX |
|---|---|---|
| Founded | 2012 | N/A |
| Country | France | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 582.2M | 611.2M |
| IPO Year | 2021 | 2026 |
Fundamental Metrics
Financial Performance| Metric | VALN | AUXX |
|---|---|---|
| Price | $5.70 | $4.74 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $12.25 | $7.85 |
| AVG Volume (30 Days) | ★ 21.9K | 13.9K |
| Earning Date | 11-12-2026 | 11-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $87.65 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.75 | $4.32 |
| 52 Week High | $12.18 | $5.95 |
Technical Indicators
Market Signals| Indicator | VALN | AUXX |
|---|---|---|
| Relative Strength Index (RSI) | 39.99 | 24.52 |
| Support Level | $5.10 | $4.32 |
| Resistance Level | $6.60 | $4.99 |
| Average True Range (ATR) | 0.20 | 0.26 |
| MACD | -0.08 | -0.05 |
| Stochastic Oscillator | 23.73 | 27.61 |
Price Performance
Historical ComparisonAbout VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.